TerrAscend Corp. (OTCMKTS:TSNDF - Get Free Report) shares dropped 8.5% during mid-day trading on Monday . The stock traded as low as $0.32 and last traded at $0.32. Approximately 522,642 shares changed hands during trading, a decline of 23% from the average daily volume of 675,144 shares. The stock had previously closed at $0.35.
TerrAscend Stock Performance
The company has a market cap of $93.65 million, a P/E ratio of -1.14 and a beta of 1.55. The firm has a 50 day moving average price of $0.40 and a 200-day moving average price of $0.63. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.69 and a current ratio of 1.35.
TerrAscend (OTCMKTS:TSNDF - Get Free Report) last released its quarterly earnings results on Thursday, March 6th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.04. The company had revenue of $74.35 million during the quarter, compared to the consensus estimate of $72.37 million. TerrAscend had a negative return on equity of 31.48% and a negative net margin of 23.95%. On average, research analysts predict that TerrAscend Corp. will post -0.14 EPS for the current year.
About TerrAscend
(
Get Free Report)
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider TerrAscend, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.
While TerrAscend currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
